A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Major Abdominal Surgery

Clinical trial NCT00718081 · COMPLETED

Trial details

NCT number: NCT00718081
Sponsor: Talphera, Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Upper or Lower Abdominal Surgery

Start date: 2008-08-01
Primary completion: 2009-03-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.